AGIOS PHARMACEUTICALS

Agios Reports Business Highlights and Third Quarter 2024 Financial Results

31 10月 2024 05:30:00 条件 Nasdaq GlobeNewswire

Agios Completes Enrollment of Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease

23 10月 2024 06:00:00 条件 Nasdaq GlobeNewswire

Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024

17 10月 2024 06:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

26 9月 2024 08:45:10 条件 NetDania Notify

Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS)

11 9月 2024 06:00:00 条件 Nasdaq GlobeNewswire

Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024

05 9月 2024 06:00:00 条件 Nasdaq GlobeNewswire

Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib

06 8月 2024 16:50:17 条件 Nasdaq GlobeNewswire

Agios Reports Business Highlights and Second Quarter 2024 Financial Results

01 8月 2024 05:31:00 条件 Nasdaq GlobeNewswire

Agios Announces Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat in Children with PK Deficiency Who Are Regularly Transfused

01 8月 2024 05:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

23 7月 2024 09:53:30 条件 NetDania Notify

Agios to Webcast Conference Call of Second Quarter 2024 Financial Results on August 1, 2024

18 7月 2024 06:00:00 条件 Nasdaq GlobeNewswire

Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress

15 6月 2024 07:45:00 条件 Nasdaq GlobeNewswire

Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ET

06 6月 2024 08:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

05 6月 2024 08:46:01 条件 NetDania Notify

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

04 6月 2024 08:46:58 条件 NetDania Notify

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

03 6月 2024 08:51:53 条件 NetDania Notify

Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia

03 6月 2024 05:30:00 条件 Nasdaq GlobeNewswire

Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

30 5月 2024 15:05:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

28 5月 2024 08:45:31 条件 NetDania Notify

Agios Announces $905 Million Purchase Agreement for Vorasidenib Royalty

28 5月 2024 06:00:00 条件 Nasdaq GlobeNewswire